← All CPC Flashcard Decks

Mixed Deck — All CPC Topics Flashcards

100 cards from real CPC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 20 Mixed Deck — All CPC Topics flashcards as text
  1. A donor requests a copy of the CCF after providing a specimen. The collector should:

    Answer: Provide Copy 5 (the donor copy) immediately

    Copy 5 of the Federal CCF is designated as the donor's copy and must be given to the donor at the time of collection.

  2. Under DOT Part 40, direct observed collection is required for which specific test category?

    Answer: Follow-up testing ordered by a Substance Abuse Professional (SAP)

    Follow-up tests ordered by a SAP after return-to-duty always require direct observation under DOT Part 40.

  3. What is the purpose of a 'return-to-duty' drug test under DOT regulations?

    Answer: To ensure a safety-sensitive employee who tested positive has tested negative before returning to safety-sensitive duties

    A return-to-duty test confirms that an employee who previously violated drug testing rules is now drug-free before resuming safety-sensitive functions.

  4. A collector must discard an insufficient specimen (shy bladder) if the donor cannot provide 30 mL after a waiting period of:

    Answer: 3 hours

    If a donor cannot provide 30 mL within 3 hours of the first attempt, the collection is discontinued under DOT Part 40.

  5. Which of the following substances is a common adulterant that some donors attempt to use to invalidate a drug test?

    Answer: Bleach or oxidizing agents introduced into the specimen cup

    Bleach and oxidizing agents are introduced into the specimen by the donor to destroy drug metabolites, and the laboratory's validity tests are designed to detect these substances.

  6. When can donor information be shared?

    Answer: Only with authorized individuals

    Donor information can only be shared with authorized individuals, typically those with a legitimate need-to-know as defined by regulations (e.g., DOT) or explicit donor consent. This includes the employer's Designated Employer Representative (DER) and the Medical Review Officer (MRO). Sharing information with unauthorized parties, such as family members or coworkers, is a breach of confidentiality and privacy laws.

  7. Which action is required when there is a blood spill on the floor before cleanup begins?

    Answer: Place absorbent material over the spill, then apply disinfectant

    Absorbent material should first be placed over the spill to contain it, then the disinfectant is applied after absorption to prevent splashing.

  8. Which statement about specimen rejection criteria is CORRECT?

    Answer: Specimens with broken or missing seals on COC packaging must be rejected and documented

    A compromised tamper-evident seal on a COC specimen indicates potential tampering; the specimen must be rejected, documented, and the discrepancy reported to the MRO or appropriate authority.

  9. Which individual in the drug-testing process has the authority to overturn a laboratory-reported positive result based on a legitimate medical explanation?

    Answer: The Medical Review Officer (MRO)

    The MRO is a licensed physician who reviews positive lab results, interviews the donor about legitimate medical explanations, and can report the result as negative if a valid explanation exists.

  10. How long should a donor be given to provide a urine specimen during a shy bladder situation?

    Answer: 3 hours

    In a shy bladder situation, a donor should be given up to three hours to provide a urine specimen. During this time, the donor is allowed to drink a reasonable amount of fluids (up to 40 ounces) under the collector's observation. This protocol ensures the donor has adequate opportunity to produce a specimen while preventing excessive fluid intake that could dilute the sample.

  11. An employee subject to DOT testing tests positive for cocaine. The MRO interviews the employee, who claims passive exposure. The MRO should:

    Answer: Verify the result as positive regardless of the claim

    Passive inhalation is not a legitimate medical explanation that allows an MRO to alter a positive result; the MRO must verify it as positive.

  12. What is the acceptable pH range for a valid urine specimen in federal drug testing?

    Answer: 4.0 to 11.0

    Under 49 CFR Part 40, a urine specimen with a pH outside the range of 4.0 to 11.0 is reported as invalid due to incompatibility with normal human physiology.

  13. Which practice breaches donor privacy?

    Answer: Leaving forms unattended

    Leaving forms unattended breaches donor privacy because sensitive personal and medical information could be viewed by unauthorized individuals. Collectors must secure all documentation immediately after use, ensuring that only authorized personnel have access. This practice is fundamental to protecting confidential information and complying with privacy regulations like HIPAA.

  14. How often should collection surfaces be disinfected?

    Answer: After every donor

    Collection surfaces must be disinfected after every donor to prevent cross-contamination and maintain a hygienic environment. This ensures that any potential spills or contaminants from one collection are removed before the next donor uses the space. Regular disinfection is a key component of infection control protocols in specimen collection.

  15. If a donor refuses a required direct observed collection under DOT regulations, the collector must:

    Answer: Document the refusal and immediately notify the Designated Employer Representative (DER)

    Refusing a required direct observed collection is treated as a refusal to test; the collector documents it and notifies the DER promptly.

  16. When a collector has reason to believe a specimen has been adulterated during collection, what is the correct next step?

    Answer: Require the donor to provide a second specimen under direct observation

    When adulteration is suspected, DOT Part 40 requires the collector to direct the donor to provide a new specimen under direct observation.

  17. A specimen is deemed 'invalid' under federal drug testing guidelines when:

    Answer: The specimen shows signs of adulteration but the adulterant cannot be identified

    An invalid result is reported when the specimen's validity testing results are outside normal physiological limits or an unidentifiable interfering substance is present, preventing a valid drug test result.

  18. The 'mini-Miranda' warning required by the FDCPA must be included in:

    Answer: Every communication with the consumer during the collection process

    The FDCPA requires that every communication with the consumer disclose that it is from a debt collector attempting to collect a debt.

  19. Which of the following best describes 'adulteration' of a urine specimen?

    Answer: Adding a foreign substance to the specimen to interfere with testing

    Adulteration involves intentionally adding a substance (such as bleach, vinegar, or commercial products) to the specimen to invalidate or mask drug test results.

  20. What does the laboratory report to the MRO when a specimen is positive on immunoassay but negative on GC-MS confirmation?

    Answer: A negative result

    If the confirmatory GC-MS test does not meet the cutoff, the specimen is reported as negative, as the confirmatory result governs the final determination.